Skip to main content
Scott Emerson on Muck Rack

Scott Emerson

Verified
Saint Lucia
As seen in: 4BC Brisbane, Sydney Morning Herald, JAMA: Journal of the American Medical Association, The Age, The Sunday Age, The New England Journal of Medicine, Brisbane Times, WAtoday, RCRWireless News, Scientific Research Publishing (SCIRP), JACC (Journal of the American College of Cardiology) and
Scott is a business consultant. He was a Qld Govt Minister and a senior journalist and commentator for The Australian, the ABC and Nine.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Scott

Contact Scott, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Register- Diamondback Energy Presents Clays Along the Pathway Sporting Clays Tournament April 11, 2025 – Stanton, TX - Upstream Calendar

|
By Scott Emerson Verified, Efrain Garcia
| Upstream Calendar
This Event Reminder is Sponsored by: Diamondback Energy Presents Clays Along the Pathway sporting clays tournament in Join us on Friday, April 11, 2025, for a day of competitive clay shooting at Windwalker Farms Sporting Clays in Martin County, Texas. This fundraising event will raise money to assist with Pathway Academy’s operating expenses
Open in Who Shared Issue with article?

Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity:

|
By Subodh Verma, Scott Emerson Verified, Jorge Plutzky, Steven Kahn
| JACC (Journal of the American College of Cardiology)
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity Sign in, Subscribe, or Pay to View
Open in Who Shared Issue with article?

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

|
By A. Michael Lincoff, Helen M. Colhoun, John Deanfield, Scott Emerson Verified
| The New England Journal of Medicine Verified
Abstract Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular risk associated with overweight and obesity in the absence of diabetes is unknown.
Open in Who Shared Issue with article?
See all 1,508 licensed articles (1,544 Total)